Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation

Liver International

Volumn 32, Issue 2, 2012, Pages 287-296

  Reese, Peter P ^a   Bloom, Roy D ^a   Feldman, Harold I ^a   Huverserian, Ari ^a   Thomasson, Arwin ^a   Shults, Justine ^a   Hamano, Takayuki ^a   Goral, Simin ^a   Shaked, Abraham ^a   Olthoff, Kimberly ^a   Rickels, Michael R ^a   Bleicher, Melissa ^a   Leonard, Mary B ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Liver transplantation; Metabolism; Vitamin D; Vitamin D binding protein

Indexed keywords

'RUGBY'; 25 HYDROXYVITAMIN D; ALBUMIN; CALCITRIOL; CALCIUM; METHYLPREDNISOLONE; MULTIVITAMIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; END STAGE LIVER DISEASE; FEMALE; HUMAN; HYPOALBUMINEMIA; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SURGICAL MORTALITY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

CALCIFEDIOL; CALCITRIOL; COHORT STUDIES; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; VITAMIN D; VITAMIN D DEFICIENCY; VITAMIN D-BINDING PROTEIN;

EID: 84855547521     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02638.x     Document Type: Article

References (42)

1. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and, ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813-8.
2. Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006; 98: 451-9.
3. Gombart AF. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol 2009; 4: 1151-65.
4. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168: 1629-37.
5. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
6. Powe CE, Ricciardi C, Berg AH, et al. Vitamin D binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 2011; 26: 1609-16.
7. Bitetto D, Fabris C, Falleti E, et al. Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver Int 2009; 30: 417-44.
8. Bikle DD, Gee E, Halloran B, Haddad JG. Free 1, 25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 1984; 74: 1966-71.
9. Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2009; 55: 2624-8.
10. Bikle DD. Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res 2007; 22(Suppl 2): V50-4.
11. Stein EM, Cohen A, Freeby M, et al. Severe vitamin D deficiency among heart and liver transplant recipients. Clin Transplant 2009; 23: 861-5.
12. Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. J Clin Invest 1986; 78: 748-52.
13. Guichelaar MM, Schmoll J, Malinchoc M, Hay JE. Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors. Hepatology 2007; 46: 1198-207.
14. Oufroukhi L, Kamar N, Muscari F, et al. Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation. Transplantation 2008; 85: 1436-42.
15. Monegal A, Navasa M, Guanabens N, et al. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 2001; 12: 484-92.
16. Compston JE, Greer S, Skingle SJ, et al. Early increase in plasma parathyroid hormone levels following liver transplantation. J Hepatol 1996; 25: 715-8.
17. Rabinovitz M, Shapiro J, Lian J, et al. Vitamin D and osteocalcin levels in liver transplant recipients. Is osteocalcin a reliable marker of bone turnover in such cases? J Hepatol 1992; 16: 50-5.
18. Crosbie OM, Freaney R, Mckenna MJ, Curry MP, Hegarty JE. Predicting bone loss following orthotopic liver transplantation. Gut 1999; 44: 430-4.
19. Feller RB, Mcdonald JA, Sherbon KJ, Mccaughan GW. Evidence of continuing bone recovery at a mean of 7 years after liver transplantation. Liver Transpl Surgery 1999; 5: 407-13.
20. Guichelaar MM, Kendall R, Malinchoc M, Hay JE. Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl 2006; 12: 1390-402.
21. Bloom RD, Reese PP. Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol 2007; 18: 3031-41.
22. Institute of Medicine. Dietary Reference Intakes Calcium Vitamin D. Washington, DC: National Academies Press, 2011.
23. De Jonge J, Kurian S, Shaked A, et al. Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts. Am J Transplant 2009; 9: 758-72.
24. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 1993; 39: 529-33.
25. Clive DR, Sudhaker D, Giacherio D, et al. Analytical and clinical validation of a radioimmunoassay for the measurement of 1, 25 dihydroxy vitamin D. Clin Biochem 2002; 35: 517-21.
26. Hollis BW. Comparison of commercially available (125)I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem 2000; 46: 1657-61.
27. Bikle DD, Siiteri PK, Ryzen E, Haddad JG. Serum protein binding of 1, 25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab 1985; 61: 969-75.
28. Bikle DD, Gee E, Halloran B, et al. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 1986; 63: 954-9.
29. UNOS. MELD/PELD calculator documentation. Available at Accessed 12 July 2009.
30. Eknoyan G, Levin A, Levin N. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-201.
31. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-54.
32. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-83.
33. Zittermann A, Schleithoff SS, Frisch S, et al. Circulating calcitriol concentrations and total mortality. Clin Chem 2009; 55: 1163-70.
34. Evenepoel P, Naesens M, Claes K, Kuypers D, Vanrenterghem Y. Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant 2007; 7: 1193-200.
35. Merion RM. Current status and future of liver transplantation. Semin Liver Dis 2010; 30: 411-21.
36. Haussler M, Whitfield G, Haussler C, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998; 13: 325-49.
37. Wolff AE, Jones AN, Hansen KE. Vitamin D and musculoskeletal health. Nat Clin Pract Rheumatol 2008; 4: 580-8.
38. Stubbs JR, Idiculla A, Slusser J, Menard R, Quarles LD. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J Am Soc Nephrol 2010; 21: 353-61.
39. Petta S, Camma C, Scazzone C, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010; 51: 1158-67.
40. Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW. Vitamin D-binding protein influences total circulating levels of 1, 25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 2008; 149: 3656-67.
41. Gines P, Arroyo V. Is there still a need for albumin infusions to treat patients with liver disease? Gut 2000; 46: 588-90.
42. Ohnishi K, Kawaguchi A, Nakajima S, Mori H, Ueshima T. A comparative pharmacokinetic study of recombinant human serum albumin with plasma-derived human serum albumin in patients with liver cirrhosis. J Clin Pharmacol 2008; 48: 203-8.